8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Date of Report (Date of earliest event reported): June 5, 2009

MEDCATH CORPORATION

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization) 000-33009
(Commission File Number) 56-2248952
(IRS Employer Identification No.)

10720 Sikes Place
Charlotte, North Carolina 28277
(Address of principal executive offices, including zip code)

(704) 708-6600
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13d-4(c))

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 5, 2009, MedCath Corporation (the “Company”) issued a press release announcing the departure of Jeffrey L. Hinton as Chief Financial Officer of the Company and the concurrent appointment of James A. Parker, Senior Vice President, Finance and Development, as Interim Chief Financial Officer, both effective on June 5, 2009.

A copy of the press release is attached hereto as Exhibit 99.1.

James A. Parker, 44, is MedCath’s Interim Chief Financial Officer and Senior Vice President, Finance and Development. Mr. Parker was appointed as Senior Vice President, Finance and Development in June 2008. Prior to that time, Mr. Parker served as MedCath’s Interim Chief Financial Officer from January- June 2008 and as Vice President, Treasurer and Director of Investor Relations since joining MedCath in March 2001. Prior to MedCath, Mr. Parker served in various positions with Bank of America. His tenure at Bank of America began in 1987 and culminated in his position as a high yield bond research analyst with responsibility for coverage of the health care industry at Banc of America Securities. Mr. Parker received his bachelor’s degree from the University of Georgia and his master’s degree in business administration from Wake Forest University’s Babcock School of Management.

Item 9.01 — Financial Statements and Exhibits

Exhibit
No.		Description
	99.1	Press Release dated June 5, 2009

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MEDCATH CORPORATION
Date: June 9, 2009	By:	/s/ James A. Parker
		James A. Parker
		Interim Chief Financial Officer

Exhibit Index

99.1 Press Release dated June 5, 2009

EX-99.1

Exhibit 99.1

MEDCATH CONTACTS:
O. Edwin French
President & Chief Executive Officer
(704) 708-6600

JEFF HINTON TO LEAVE MEDCATH
Art Parker Named Interim Chief Financial Officer

     CHARLOTTE, N.C., June 5, 2009 — MedCath Corporation (Nasdaq: MDTH), a healthcare provider focused on high acuity healthcare services, predominately the diagnosis and treatment of cardiovascular disease, today announced that Art Parker, Senior Vice President, Finance and Development, has been named Interim Chief Financial Officer. Parker replaces Jeff Hinton, whose employment with MedCath has ended effective immediately.

     “Art has been a long-time participant as a member of senior management and is well-known to the investor community, banking community, and throughout MedCath as a very capable financial manager,” said Ed French, MedCath’s President and Chief Executive Officer. “He is very much engaged in all of our assets and has worked closely over the past years with our very capable accounting and finance team. I’m delighted to have him step up and provide leadership as Interim CFO.”

     MedCath has engaged an executive search firm to identify a permanent Chief Financial Officer candidate.

     MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns an interest in and operates nine hospitals with a total of 755 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas. MedCath is in the process of developing its tenth hospital, which is anticipated to open in fall 2009, in Kingman, Ariz. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.